Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
Journal: Molecular oncology
Published: September 08, 2025
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: March 30, 2023
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Journal: Cancer discovery
Published: July 29, 2020
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair.
Journal: Nature communications
Published: June 03, 2020
Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk.
Journal: Oncotarget
Published: February 26, 2019
PARP-1 regulates DNA repair factor availability.
Journal: EMBO molecular medicine
Published: November 24, 2018
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2018
Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer.
Journal: Oncotarget
Published: July 27, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2016
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.
Journal: Journal of translational medicine
Published: April 14, 2015
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
Journal: Journal of the National Cancer Institute
Published: May 21, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026